middle.news
Neurizon Accelerates $1.5M Funding Using 2025 R&D Tax Rebate
9:20am on Wednesday 30th of July, 2025 AEST
•
Biotechnology
Read Story
Neurizon Accelerates $1.5M Funding Using 2025 R&D Tax Rebate
9:20am on Wednesday 30th of July, 2025 AEST
Key Points
Secured $1.5 million loan from Radium Capital
Loan backed by a portion of 2025 Australian R&D Tax Rebate
Non-dilutive funding preserves shareholder equity
Interest rate set at 17% per annum
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE